Characterizing the continuously acquired cardiovascular time series during hemodialysis, using median hybrid filter

Scott Wilson1, Andrea Bowyer2, Stephen B Harrap3

  • 1Department of Renal Medicine, The Alfred Hospital, Melbourne, Australia ; Baker IDI, Melbourne, Australia.

Insights

A novel median hybrid filter (MHF) improves continuous systolic blood pressure (SBP) monitoring during hemodialysis (HD). This method offers accurate, real-time hemodynamic data for better cardiovascular risk assessment in HD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Physiology
  • Biomedical Engineering

Background:

  • Cardiovascular dynamics during hemodialysis (HD) are crucial for patient diagnosis, risk assessment, and treatment efficacy.
  • Current methods for detecting intradialytic systolic blood pressure (SBP) changes in HD patients are imprecise and rely on symptomatic hypotension and intermittent noninvasive brachial cuff blood pressure (NIBP) readings.

Purpose of the Study:

  • To develop and evaluate a signal preprocessing technique for continuous noninvasive SBP monitoring during HD.
  • To assess the efficacy of a novel median hybrid filter (MHF) algorithm in handling noise and artifacts in cardiovascular data.

Main Methods:

  • Prospectively collected continuous noninvasive SBP data from ten HD patients during a short-break intradialytic period.
  • Preprocessing of SBP data using a novel median hybrid filter (MHF) algorithm.
  • Comparison of MHF-processed data with 50 time-coincident intradialytic NIBP measurements from routine HD practice.

Main Results:

  • The MHF preprocessing technique effectively produced a dynamic regression of cardiovascular data without significant noise and artifacts.
  • The processed SBP data is suitable for high-level profiling of time-dependent SBP behavior.
  • Signal accuracy using MHF was highly comparable to standard NIBP measurements.

Conclusions:

  • The MHF algorithm provides a robust solution for preprocessing continuous cardiovascular data during HD.
  • This technique offers dynamic, real-time hemodynamic information, enhancing clinical decision-making and patient monitoring.
  • Continuous SBP monitoring with MHF preprocessing improves upon traditional intermittent NIBP measurements for HD patients.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.7K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.0K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.7K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.0K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.3K